Weekly irinotecan plus UFT and leucovorin as first-line chemotherapy of patients with advanced colorectal cancer

By Méndez M.   Alfonso P.   Pujol E.   González E.   Castañon C.   Cerezuela P.   López-Mateos Y.   Cruz J.  

Investigational New Drugs, Vol. 23, Iss. 3, 2005-06 ,pp. : 243-251

Springer Publishing Company

Access to resources Recommend Favorite

Benefit-Risk Assessment of Irinotecan in Advanced Colorectal Cancer

By Glimelius Bengt  

Drug Safety, Vol. 28, Iss. 5, 2005-01 ,pp. : 417-433

Adis International

Access to resources Recommend Favorite

Irinotecan cost effective in metastatic colorectal cancer

By  

Inpharma, Vol. 1, Iss. 1226, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer

By Cao Shousong   Bhattacharya Arup   Durrani Farukh A   Fakih Marwan  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 687-703

Informa Healthcare

Access to resources Recommend Favorite

Cost––effectiveness of UGT1A1 genotyping in second-line, high-dose, once every 3 weeks irinotecan monotherapy treatment of colorectal cancer

By Obradovic Marko   Mrhar Ales   Kos Mitja  

Pharmacogenomics, Vol. 9, Iss. 5, 2008-05 ,pp. : 539-549

Future Medicine

Access to resources Recommend Favorite